Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
Holding NVCT?
Track your performance easily

Nuvectis Pharma (NVCT) Financial Statements

75 Followers

Nuvectis Pharma Financial Overview

Nuvectis Pharma's market cap is currently ―. The company's EPS TTM is $-1.259; its P/E ratio is -5.90; Nuvectis Pharma is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit---$ -3.50M-
EBIT$ -4.15M$ -4.43M$ -4.40M$ -6.87M$ -6.16M
EBITDA$ -4.15M$ -4.43M$ -4.40M$ -6.87M-
Net Income Common Stockholders$ -4.15M$ -4.43M$ -4.17M$ -6.62M$ -5.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.20M$ 18.10M$ 19.50M$ 19.10M$ 22.10M
Total Assets$ 17.31M$ 18.30M$ 19.71M$ 19.18M$ 22.26M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -17.20M$ -18.10M$ -19.50M$ -19.10M$ -22.10M
Total Liabilities$ 6.32M$ 5.77M$ 5.69M$ 6.98M$ 5.58M
Stockholders Equity$ 10.99M$ 12.57M$ 14.02M$ 12.20M$ 16.69M
Cash Flow-
Free Cash Flow$ -2.40M$ -3.02M$ -4.36M$ -3.85M-
Operating Cash Flow$ -2.40M$ -3.02M$ -4.36M$ -3.85M$ -3.24M
Investing Cash Flow-----
Financing Cash Flow$ 1.46M$ 1.67M$ 4.70M$ 917.00K$ 703.00K
Currency in USD

Nuvectis Pharma Earnings and Revenue History

Nuvectis Pharma Debt to Assets

Nuvectis Pharma Cash Flow

Nuvectis Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis